[Breaking] FDA Grants Emergency Use Authorization for Johnson & Johnson Single-Dose COVID Vaccine

[Asia Economy Reporter Lim Juhyung] The U.S. Food and Drug Administration (FDA) announced on the 27th (local time) that it has granted emergency use authorization for Johnson & Johnson (J&J)'s COVID-19 vaccine, according to reports from AP and AFP.

The FDA accepted the recommendation made the previous day by its advisory committee, the Vaccines and Related Biological Products Advisory Committee (VRBPAC), which voted to approve the emergency use of J&J's COVID-19 vaccine.

The advisory committee unanimously recommended granting emergency use authorization for the J&J vaccine to be administered to American adults aged 18 and older.

With this, the U.S. has secured a third COVID-19 vaccine available for Americans, following the Pfizer-BioNTech and Moderna vaccines.

Unlike other vaccines, the Johnson & Johnson vaccine can prevent COVID-19 with a single dose.

This content was produced with the assistance of AI translation services.